Pharminent

FDA approves Viatris’ Ryzumvi for adult presbyopia

The US FDA has approved Viatris’ Ryzumvi (phentolamine ophthalmic solution 0.75%) for the treatment of presbyopia in adults.

MHRA could allow schools to stock nasal adrenaline spray

The MHRA could allow schools to hold reserve supplies of nasal adrenaline spray, adding an easy-to-use option alongside the autoinjectors such as EpiPen that schools already store.

Gilead’s oral IBD drug eliminates symptoms in phase 2 trial

An oral treatment from Gilead Sciences eliminated symptoms in patients with a type of inflammatory bowel disease, according to mid-stage study results reported Monday.

Novartis abandons Fabhalta trial in lupus nephritis

Novartis is abandoning its lupus nephritis trial of Fabhalta after a phase 2 study failed, ending its effort to extend the drug’s approved indications to the disease.

GSK reports first international trial data for ADC ris-rez

GSK has reported the first data from its international trial of B7-H3-targeted antibody-drug conjugate ris-rez in small cell lung cancer, which back up earlier results from a Chinese study.

OMass secures $310M for congenital adrenal hyperplasia candidate

OMass has secured $310 million to advance its molecule for congenital adrenal hyperplasia, a rare endocrine disorder.

Nouscom raises €120M Series D for Lynch syndrome vaccine

Swiss biotech Nouscom has raised a €120 million Series D to support trials of a Lynch syndrome vaccine, with Soufflé, Estuary and Microbiotica also announcing financings.

Estuary launches with $103M for kidney gene therapies

Estuary Biotherapeutics has launched with $103 million in total committed financing to develop targeted gene therapies for kidney diseases.

GSK-backed DASH quality-record platform goes commercial

DASH (Data Acquisition and Standardisation Hub), a digital platform for exchanging pharmaceutical quality records between supply-chain partners, is now commercially available following an Innovate UK-funded project involving GSK, the University of Cambridge and CPI; it converts Certificates of Analysis from formats including PDF, Excel and CSV into structured data and cuts approval times by up to 90%.

Beckman Coulter Diagnostics names Catherine Jennings president

Beckman Coulter Diagnostics has appointed Catherine Jennings as its new president, where she will lead the company’s strategic, operational and organizational priorities. Jennings brings more than 20 years of healthcare industry leadership.

Immunology association split over $8.4B California research measure

Internal emails obtained by STAT show the American Association of Immunologists is sharply divided over California’s Proposition 38, which would provide $8.4 billion in taxpayer dollars for immunology research.